UCB - 销售收入

股票价格
227.70
每天变化
-10.20 -4.29%
每月一次
-10.14%
每年
46.06%
Q2 预测
233.96




销售 更改 日
Alcon AG USD 2.7B 110M 2025-12
Almirall EUR 547.63M 12.83M 2025-12
Amarin USD 49.22M 451K 2025-12
argenx SE USD 1.12B 132.91M 2025-12
AstraZeneca USD 15.5B 313M 2025-12
Bayer EUR 11.44B 1.78B 2025-12
Galapagos EUR 900.82M 835.52M 2025-12
Genmab DKK 1.06B 36M 2025-12
GlaxoSmithKline GBP 8.62B 73M 2025-12
GRIFOLS EUR 1.98B 110M 2025-12
Hikma Pharmaceutical USD 1.69B 863M 2025-12
Lonza CHF 3.58B 63M 2025-06
Merck EUR 5.25B 70M 2025-12
Novartis USD 13.11B 226M 2026-03
Orion EUR 417.7M 277.6M 2026-03
Recordati EUR 662M 37.65M 2025-12
Roche Holding CHF 15.65B 274.5M 2025-12
Sanofi EUR 11.24B 60M 2026-03
UCB EUR 4.25B 764M 2025-12
Unibail Rodamco EUR 1.49B 77M 2025-12